Curaderm-BEC5 the Treatment of Choice You and Your Family have been Waiting For!
The established treatments for non-melanoma skin cancers are surgery, Mohs technique, cryotherapy, curettage with cautery and radio therapy. However, in recent years, Skin Cancer Clinics, Medical Professionals, Magazines, Naturopaths and Consumers throughout the USA, and
United Kingdom and Australia have ncreasingly been recommending Curaderm-BEC5 as the Treatment of Choice for non-melanoma skin cancer. In fact, over 80,000 people have now used Curaderm-BEC5.
You may not be aware that this cancer research has existed for over twenty years in Australia. The research has resulted in identifying Solasodine Glycosides which are glycoalkaloids, and are extracted from plant material, with excellent antineoplastic (anti-cancer) activity using a novel mode of action.
This work has resulted in interest world-wide and many centres are elaborating on the Australian findings.
Phase II clinical trials for internal terminal tumours using the glycoalkaloids are now underway in Western Australia.
We will have to await these results to see how effective these new antineoplastics are for internal cancers in man.
However, we do not have to wait for a simple, novel, elegant Skin Cancer Treatment, as Curaderm-BEC5 Cream is the only clinically proven treatment now available. This product has over 2 decades clinical experience for the treatment of BCCs, SCCs and Sunspots.
has now been confirmed by a plethora of scientists world-wide. In particular the effective treatment of BCC with Curaderm-BEC5 has now been confirmed by ten independent centres in the United Kingdom. These centres have completed Phase III and open studies using Curaderm-BEC5 for the treatment of BCCs and the dermatologists at The concluded that with Curaderm-BEC5 The original research carried out by Dr Cham in Australia
"We consider that this rate of treatment success more than justifies the physician considering alternative to currently predominant treatments such as surgical excision or cryotherapy. In our view and experience [Curaderm] BEC5 is a topical preparation, which is safe and effective, ideal therapy for outpatient treatment.
Hence [Curaderm] BEC5 is a much needed alternative to surgery for basal cell carcinoma. This is the commonest cancer in Caucasions worldwide and the prevalence continues to increase with an increasing ageing population. It is a cost effective treatment for both primary and secondary skin cancer care."
